InspireMD (NSPR) Shares are Down -15.12%

InspireMD (NSPR) : During the past 4 weeks, traders have been relatively bearish on InspireMD (NSPR), hence the stock is down -27.94% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -15.57% relative to the S&P 500. The 4-week change in the price of the stock is -29.4% and the stock has fallen -15.12% in the past 1 week.

The stock has recorded a 20-day Moving Average of 19.6% and the 50-Day Moving Average is 33.57%.The 200 Day SMA reached 75.97% InspireMD, Inc. has dropped 70.19% during the last 3-month period . Year-to-Date the stock performance stands at -87.5%.


For the current week, the company shares have a recommendation consensus of Buy. InspireMD (NYSEMKT:NSPR): The stock was completely flat for the day, closing at $0.11 on Friday. The flat closing masks the intraday volatility in the stock. After opening at $0.10, the stock touched an intraday high of $0.12 and a low of $0.10. Neither the bulls nor the bears asserted their supremacy at close, due to which the stock closed completely flat. The stock previously closed at $0.11. The total trading volume on Friday was 932,363.

InspireMD, Inc. is a medical device company. The Company is focused on the development and commercialization of its MicroNet stent platform technology for the treatment of complex coronary and vascular disease. The Companys MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. The Companys MGuard coronary products combining MicroNet and a bare-metal stent (MGuard Prime Embolic Protection Stent (EPS)) are marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). The Companys second product CGuard carotid embolic prevention system (EPS) combines MicroNet and a self-expandable nitinol stent in a single device to treat carotid artery disease. The Company is also developing a pipeline of other products and additional applications by leveraging its MicroNet technology.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.